Files
Document type
ArticleVersion
Published versionPublication date
Publication license
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/126638
Real World Study to Evaluate the Effectiveness of Varenicline and Cognitive-Behavioural Interventions for Smoking Cessation
Journal Title
Director/Tutor
Journal ISSN
Volume Title
Related resource
Abstract
A prospective pragmatic interventional study was conducted to evaluate the effectiveness of varenicline for smoking cessation among a cohort of motivated smokers attending two smoking cessation clinics. Smokers between 18 and 65 years who had smoked 10 or more cigarettes per day were included. All participants received cognitive-behavioural varenicline according to approved dose and prescriptions. Continuous abstinence, validated by exhaled CO levels, was assessed in each control. A total of 264 smokers - 155 males (58.7%) and 109 females (41.3%) - were included. Mean age was 43.7, amount smoked was 23 cigarettes per day and 61.4% had at least one prior attempt to quit. The continuous abstinence rate at end of treatment (12 wks) was 58.3%. Conclusions: varenicline and cognitive-behavioural intervention are effective for smoking cessation with high continuous abstinence rates when are used in a clinical setting.
Subject (English)
Citation
Citation
RAMON TORRELL, Josep M. (Josep Maria) and BRUGUERA, Eugeni. Real World Study to Evaluate the Effectiveness of Varenicline and Cognitive-Behavioural Interventions for Smoking Cessation. International Journal of Environmental Research and Public Health. 2009. Vol. 6, num. 4, pags. 1530-1538. [consulted: 19 of August of 2026]. Available at: https://hdl.handle.net/2445/126638